Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Dive

Showing results (181-190 of 207) with videos related to

Pageof 21
Sort By:
Acta Gastro-Enterologica Belgica|January 1, 1989
[Is jaundice a cause of error in the interpretation of CA 19-9 blood levels?]A Nakad, J F Colombel, A P Geubel, et al.
Gastroenterology|October 1, 1988
Massive plasma cell infiltration of the digestive tract. Secretory component as the rate-limiting factor of immunoglobulin secretion in external fluidsJ F Colombel, J C Rambaud, J P Vaerman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 3, 2019
How liquid biopsies can change clinical practice in oncologyG Siravegna, B Mussolin, T Venesio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 29, 2008
Optimisation of circulating biomarkers of cell death for routine clinical useA Greystoke, J Cummings, T Ward, et al.
British Journal of Cancer|July 24, 2008
Reciprocal relationship between expression of hypoxia inducible factor 1alpha (HIF-1alpha) and the pro-apoptotic protein bid in ex vivo colorectal cancerM M Seenath, D Roberts, C Cawthorne, et al.
British Journal of Cancer|December 22, 2011
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarkerL Khoja, A Backen, R Sloane, et al.
British Journal of Cancer|June 4, 2009
Preclinical efficacy of the bioreductive alkylating agent RH1 against paediatric tumoursD Hussein, S V Holt, K E Brookes, et al.
British Journal of Cancer|October 19, 2013
A study to investigate dose escalation of doxorubicin in ABVD chemotherapy for Hodgkin lymphoma incorporating biomarkers of response and toxicityA Gibb, A Greystoke, M Ranson, et al.
British Journal of Cancer|January 20, 2011
Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphomaA Greystoke, J P B O'Connor, K Linton, et al.
British Journal of Cancer|February 3, 2005
Expression of the proapoptotic protein Bid is an adverse prognostic factor for radiotherapy outcome in carcinoma of the cervixM M L Green, G J Hutchison, H R Valentine, et al.
Pageof 21

Showing results (181-190 of 207) with videos related to

Sort By:
Pageof 21
Acta Gastro-Enterologica Belgica|January 1, 1989
[Is jaundice a cause of error in the interpretation of CA 19-9 blood levels?]A Nakad, J F Colombel, A P Geubel, et al.
Gastroenterology|October 1, 1988
Massive plasma cell infiltration of the digestive tract. Secretory component as the rate-limiting factor of immunoglobulin secretion in external fluidsJ F Colombel, J C Rambaud, J P Vaerman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 3, 2019
How liquid biopsies can change clinical practice in oncologyG Siravegna, B Mussolin, T Venesio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 29, 2008
Optimisation of circulating biomarkers of cell death for routine clinical useA Greystoke, J Cummings, T Ward, et al.
British Journal of Cancer|July 24, 2008
Reciprocal relationship between expression of hypoxia inducible factor 1alpha (HIF-1alpha) and the pro-apoptotic protein bid in ex vivo colorectal cancerM M Seenath, D Roberts, C Cawthorne, et al.
British Journal of Cancer|December 22, 2011
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarkerL Khoja, A Backen, R Sloane, et al.
British Journal of Cancer|June 4, 2009
Preclinical efficacy of the bioreductive alkylating agent RH1 against paediatric tumoursD Hussein, S V Holt, K E Brookes, et al.
British Journal of Cancer|October 19, 2013
A study to investigate dose escalation of doxorubicin in ABVD chemotherapy for Hodgkin lymphoma incorporating biomarkers of response and toxicityA Gibb, A Greystoke, M Ranson, et al.
British Journal of Cancer|January 20, 2011
Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphomaA Greystoke, J P B O'Connor, K Linton, et al.
British Journal of Cancer|February 3, 2005
Expression of the proapoptotic protein Bid is an adverse prognostic factor for radiotherapy outcome in carcinoma of the cervixM M L Green, G J Hutchison, H R Valentine, et al.
Pageof 21